VICARIOUS SURGICAL INC-A (RBOT) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:RBOT - US92561V2088 - Common Stock
1.95 USD
-0.01 (-0.51%)
2.03 USD
+0.08 (+4.1%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 21.81M | 13.848M -36.51% | -100.00% | 9.69M | 21.624M 123.16% | 65.79M 204.25% | 134.44M 104.35% | |||
| EBITDA YoY % growth | -78.97M -108.36% | -78.812M 0.20% | -64.448M 18.23% | -33.66M 47.77% | -33.66M | -8.16M 75.76% | N/A | N/A | N/A | |
| EBIT YoY % growth | -80.08M -109.52% | -80.666M -0.73% | -66.555M 17.49% | -61.2M 8.05% | -69.36M -13.33% | -51M 26.47% | N/A | N/A | N/A | |
| Operating Margin | N/A | -369.85% | -480.62% | N/A | N/A | -526.32% | N/A | N/A | N/A | |
| EPS YoY % growth | -13.50 26.47% | -14.70 -8.89% | -10.85 26.19% | -7.96 26.63% | -4.60 42.28% | -4.23 7.88% | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.40 40.79% | -1.22 52.92% | -1.17 47.40% | -1.12 39.68% | -0.62 55.47% | -0.36 70.83% | -0.51 56.52% | -0.67 40.00% | -0.68 -9.84% |
| Revenue Q2Q % growth | 3.06M | 4.284M | 5.712M | 5.814M | |||||
| EBITDA Q2Q % growth | -8.16M 36.60% | -8.16M 46.94% | -8.16M 35.93% | -8.16M 21.30% | -8.16M | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.3M -2.15% | -17.34M -10.12% | -17.34M -28.26% | -17.34M -50.74% | -17.34M -13.33% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.86 35.86% | -2.37 | 0.51 | 21.62% |
| Q2 2025 Q2Q % growth | -2.23 13.90% | -2.55 | 0.32 | 12.43% |
| Q1 2025 Q2Q % growth | -2.60 13.33% | -2.53 | -0.07 | -2.78% |
| Q4 2024 Q2Q % growth | -2.36 -31.11% | -2.74 | 0.38 | 13.99% |
| Q3 2024 Q2Q % growth | -2.90 3.33% | -2.61 | -0.29 | -11.28% |
| Q2 2024 Q2Q % growth | -2.59 28.06% | -2.83 | 0.24 | 8.50% |
| Q1 2024 Q2Q % growth | -3.00 52.38% | -2.91 | -0.09 | -3.20% |
| Q4 2023 Q2Q % growth | -1.80 33.33% | -3.83 | 2.03 | 52.94% |
| Q3 2023 Q2Q % growth | -3.00 50.00% | -4.36 | 1.36 | 31.20% |
| Q2 2023 Q2Q % growth | -3.60 -1,100.00% | -4.36 | 0.76 | 17.44% |
| Q1 2023 Q2Q % growth | -6.30 -40.00% | -4.13 | -2.17 | -52.51% |
| Q4 2022 Q2Q % growth | -2.70 40.00% | -5.30 | 2.60 | 49.09% |
| Q3 2022 Q2Q % growth | -6.00 -122.22% | -4.74 | -1.26 | -26.50% |
| Q2 2022 Q2Q % growth | -0.30 | -4.44 | 4.14 | 93.24% |
| Q1 2022 Q2Q % growth | -4.50 | -4.01 | -0.49 | -12.09% |
| Q4 2021 Q2Q % growth | -4.50 | -3.19 | -1.31 | -41.06% |
| Q3 2021 Q2Q % growth | -2.70 | -1.84 | -0.86 | -47.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 16.99% | 32.43% | 7.61% | 11.56% |
| Revenue | N/A | N/A | N/A | N/A |